{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:56:20Z","timestamp":1765486580946},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Implantable cardioverter defibrillators are implanted on a\u00a0large scale in patients with heart failure (HF) for the prevention of sudden cardiac death. There are different scenarios in which defibrillator therapy is no longer desired or indicated, and this is occurring increasingly in elderly patients. Usually device therapy is continued until the device has reached battery depletion. At that time, the decision needs to be made to either replace it or to downgrade to a\u00a0pacing-only device. This decision is dependent on many factors, including the vitality of the patient and his\/her preferences, but may also be influenced by changes in recommendations in guidelines. In the last few years, there has been an increased awareness that discussions around these decisions are important and useful. Advanced care planning and shared decision-making have become important and are increasingly recognised as such. In this short review we describe six elderly patients with HF, in whose cases we discussed these issues, and we aim to provide some scientific and ethical rationale for clinical decision-making in this context. Current guidelines advocate the discussion of end-of-life options at the time of device implantation, and physicians should realise that their choices influence patients\u2019 options in this critical phase of their illness.<\/jats:p>","DOI":"10.1007\/s12471-021-01555-w","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T10:02:37Z","timestamp":1615543357000},"page":"243-252","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Downgrade of cardiac defibrillator devices to pacemakers in elderly heart failure patients: clinical considerations and the importance of shared decision-making"],"prefix":"10.1007","volume":"29","author":[{"given":"H. F.","family":"Groenveld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Coster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rienstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Blaauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H.","family":"Maass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"1555_CR1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski\u00a0P, Voors\u00a0AA, Anker\u00a0SD, et\u00a0al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart\u00a0J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"key":"1555_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ejhf.1323","volume":"21","author":"JP Ferreira","year":"2019","unstructured":"Ferreira\u00a0JP, Metra\u00a0M, Mordi\u00a0I, et al. Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study. Eur J Heart Fail. 2019;21:112\u201320.","journal-title":"Eur J Heart Fail"},{"key":"1555_CR3","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/eurjhf\/hfp149","volume":"11","author":"DJ van Veldhuisen","year":"2009","unstructured":"van Veldhuisen\u00a0DJ, Maass\u00a0AH, Priori\u00a0SG, et\u00a0al. Implementation of device therapy (cardiac resynchronisation therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail. 2009;11:1143\u201351.","journal-title":"Eur J Heart Fail"},{"key":"1555_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1609758","volume":"377","author":"L Shen","year":"2017","unstructured":"Shen\u00a0L, Jhund\u00a0PS, Petrie\u00a0MC, et\u00a0al. Declining risk of sudden death in heart failure. N\u00a0Engl J Med. 2017;377:41\u201351.","journal-title":"N Engl J Med"},{"key":"1555_CR5","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","volume":"375","author":"L Kober","year":"2016","unstructured":"Kober\u00a0L, Thune\u00a0JJ, Nielsen\u00a0JC, et\u00a0al. Defibrillator implantation in patients with nonischemic systolic heart failure. N\u00a0Engl J Med. 2016;375:1221\u201330.","journal-title":"N Engl J Med"},{"key":"1555_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ahj.2003.12.017","volume":"147","author":"AD Krahn","year":"2004","unstructured":"Krahn\u00a0AD, Connolly\u00a0SJ, Roberts\u00a0RS, Gent\u00a0M. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am Heart\u00a0J. 2004;147:837\u201340.","journal-title":"Am Heart J"},{"key":"1555_CR7","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/ejhf.1541","volume":"21","author":"S Coiro","year":"2019","unstructured":"Coiro\u00a0S, Girerd\u00a0N, Sharma\u00a0A, et al. Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failure. Eur J Heart Fail. 2019;21:1248\u201358.","journal-title":"Eur J Heart Fail"},{"key":"1555_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/pace.13869","volume":"43","author":"G Mattsson","year":"2020","unstructured":"Mattsson\u00a0G, Magnusson\u00a0P. Long-term follow-up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality. Pacing Clin Electrophysiol. 2020;43:245\u201353.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1555_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/clc.23315","volume":"43","author":"PL Hess","year":"2020","unstructured":"Hess\u00a0PL, Matlock\u00a0DD, Al-Khatib\u00a0SM. Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults. Clin Cardiol. 2020;43:187\u201395.","journal-title":"Clin Cardiol"},{"key":"1555_CR10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s12471-017-1016-x","volume":"25","author":"M van Barreveld","year":"2017","unstructured":"van Barreveld\u00a0M, Dijkgraaf\u00a0MGW, Hulleman\u00a0M, et al. Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a\u00a0prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator. Neth Heart\u00a0J. 2017;25:574\u201380.","journal-title":"Neth Heart J"},{"key":"1555_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/europace\/euw157","volume":"18","author":"R Tilz","year":"2016","unstructured":"Tilz\u00a0R, Boveda\u00a0S, Deharo\u00a0J, Dobreanu\u00a0D, Haugaa\u00a0KH, Dagres\u00a0N. Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European heart rhythm association survey. Europace. 2016;18:945\u20139.","journal-title":"Europace"},{"key":"1555_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.hfc.2019.12.006","volume":"16","author":"K Kida","year":"2020","unstructured":"Kida\u00a0K, Doi\u00a0S, Suzuki\u00a0N. Palliative care in patients with advanced heart failure. Heart Fail Clin. 2020;16:243\u201354.","journal-title":"Heart Fail Clin"},{"key":"1555_CR13","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1007\/s11606-019-05482-w","volume":"35","author":"M Schichtel","year":"2020","unstructured":"Schichtel\u00a0M, Wee\u00a0B, Perera\u00a0R, Onakpoya\u00a0I. The effect of advance care planning on heart failure: a\u00a0systematic review and meta-analysis. J\u00a0Gen Intern Med. 2020;35:874\u201384.","journal-title":"J Gen Intern Med"},{"key":"1555_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1056\/NEJMp1510020","volume":"374","author":"TR Fried","year":"2016","unstructured":"Fried\u00a0TR. Shared decision making\u2014finding the sweet spot. N\u00a0Engl J Med. 2016;374:104\u20136.","journal-title":"N Engl J Med"},{"key":"1555_CR15","doi-asserted-by":"publisher","first-page":"e005619","DOI":"10.1161\/CIRCHEARTFAILURE.118.005619","volume":"12","author":"JH Thompson","year":"2019","unstructured":"Thompson\u00a0JH, Thylen\u00a0I, Moser\u00a0DK. Shared decision-making about end-of-life care scenarios compared among implantable cardioverter defibrillator patients: a\u00a0national cohort study. Circ Heart Fail. 2019;12:e5619.","journal-title":"Circ Heart Fail"},{"key":"1555_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.113.002648","volume":"129","author":"A Kinch Westerdahl","year":"2014","unstructured":"Kinch Westerdahl\u00a0A, Sj\u00f6blom\u00a0J, Mattiasson\u00a0A, Rosenqvist\u00a0M, Frykman\u00a0V. Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life. Circulation. 2014;129:422\u20139.","journal-title":"Circulation"},{"key":"1555_CR17","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S0735-1097(98)00359-3","volume":"32","author":"EM Grubman","year":"1998","unstructured":"Grubman\u00a0EM, Pavri\u00a0BB, Shipman\u00a0T, Britton\u00a0N, Kocovic\u00a0DZ. Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators. J\u00a0Am Coll Cardiol. 1998;32:1056.","journal-title":"J Am Coll Cardiol"},{"key":"1555_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11886-019-1236-3","volume":"21","author":"M Akhtar","year":"2019","unstructured":"Akhtar\u00a0M, Elliott\u00a0PM. Risk stratification for sudden cardiac death in non-ischaemic dilated cardiomyopathy. Curr Cardiol Rep. 2019;21:155.","journal-title":"Curr Cardiol Rep"},{"key":"1555_CR19","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1161\/CIRCULATIONAHA.117.028829","volume":"136","author":"MB Elming","year":"2017","unstructured":"Elming\u00a0MB, Nielsen\u00a0JC, Haarbo\u00a0J, et al. Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure. Circulation. 2017;136:1772\u201380.","journal-title":"Circulation"},{"key":"1555_CR20","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/jce.12496","volume":"25","author":"FA Sebag","year":"2014","unstructured":"Sebag\u00a0FA, Lellouche\u00a0N, Chen\u00a0Z, et al. Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT\u2011D. J\u00a0Cardiovasc Electrophysiol. 2014;25:1368\u201375.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1555_CR21","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1161\/CIRCULATIONAHA.114.011283","volume":"130","author":"MH Ruwald","year":"2014","unstructured":"Ruwald\u00a0MH, Solomon\u00a0SD, Foster\u00a0E, et al. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT) trial. Circulation. 2014;130:2278\u201386.","journal-title":"Circulation"},{"key":"1555_CR22","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/eurheartj\/ehl099","volume":"27","author":"JG Cleland","year":"2006","unstructured":"Cleland\u00a0JG, Daubert\u00a0JC, Erdmann\u00a0E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase. Eur Heart\u00a0J. 2006;27:1928\u201332.","journal-title":"Eur Heart J"},{"key":"1555_CR23","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/pace.12174","volume":"36","author":"M Manne","year":"2013","unstructured":"Manne\u00a0M, Rickard\u00a0J, Varma\u00a0N, Chung\u00a0MK, Tchou\u00a0P. Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalises survival. Pacing Clin Electrophysiol. 2013;36:970\u20137.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1555_CR24","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/europace\/eux323","volume":"20","author":"ML Narducci","year":"2018","unstructured":"Narducci\u00a0ML, Biffi\u00a0M, Ammendola\u00a0E, et al. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT\u2011D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT\u2011D analysis. Europace. 2018;20:1475\u201383.","journal-title":"Europace"},{"key":"1555_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12471-015-0800-8","volume":"24","author":"IA ter Horst","year":"2016","unstructured":"ter Horst\u00a0IA, van\u2019t Sant\u00a0J, Wijers\u00a0SC, Vos\u00a0MA, Cramer\u00a0MJ, Meine\u00a0M. The risk of ventricular arrhythmias in a\u00a0Dutch CRT population: CRT-defibrillator versus CRT-pacemaker. Neth Heart\u00a0J. 2016;24:204\u201313.","journal-title":"Neth Heart J"},{"key":"1555_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/CIRCEP.112.000214","volume":"6","author":"JA Manfredi","year":"2013","unstructured":"Manfredi\u00a0JA, Al-Khatib\u00a0SM, Shaw\u00a0LK, et al. Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias. Circ Arrhythm Electrophysiol. 2013;6:257\u201364.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1555_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/europace\/eut339","volume":"16","author":"M Zecchin","year":"2014","unstructured":"Zecchin\u00a0M, Proclemer\u00a0A, Magnani\u00a0S, et al. Long-term outcome of \u2018super-responder\u2019 patients to cardiac resynchronization therapy. Europace. 2014;16:363\u201371.","journal-title":"Europace"},{"key":"1555_CR28","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1016\/S1470-2045(18)30348-6","volume":"19","author":"E Soto-Perez-de-Celis","year":"2018","unstructured":"Soto-Perez-de-Celis\u00a0E, Li\u00a0D, Yuan\u00a0Y, Lau\u00a0YM, Hurria\u00a0A. Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer. Lancet Oncol. 2018;19:e305\u201316.","journal-title":"Lancet Oncol"},{"key":"1555_CR29","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/pace.12353","volume":"37","author":"A Stromberg","year":"2014","unstructured":"Stromberg\u00a0A, Fluur\u00a0C, Miller\u00a0J, Chung\u00a0ML, Moser\u00a0DK, Thylen\u00a0I. ICD recipients\u2019 understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life. Pacing Clin Electrophysiol. 2014;37:834\u201342.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1555_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/1573403X14666180123165203","volume":"14","author":"J Chow","year":"2018","unstructured":"Chow\u00a0J, Senderovich\u00a0H. It\u2019s time to talk: challenges in providing integrated palliative care in advanced congestive heart failure. a\u00a0narrative review. Curr Cardiol Rev. 2018;14:128\u201337.","journal-title":"Curr Cardiol Rev"},{"key":"1555_CR31","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1177\/0269216318801162","volume":"32","author":"LA Kernick","year":"2018","unstructured":"Kernick\u00a0LA, Hogg\u00a0KJ, Millerick\u00a0Y, Murtagh\u00a0FEM, Djahit\u00a0A, Johnson\u00a0M. Does advance care planning in addition to usual care reduce hospitalisation for patients with advanced heart failure: a\u00a0systematic review and narrative synthesis. Palliat Med. 2018;32:1539\u201351.","journal-title":"Palliat Med"},{"key":"1555_CR32","doi-asserted-by":"publisher","first-page":"e007134","DOI":"10.1161\/CIRCEP.118.007134","volume":"12","author":"JZ Li","year":"2019","unstructured":"Li\u00a0JZ, Bhonsale\u00a0A, Estes\u00a0NAM, et al. Trends and implications of DF\u20114 implantable cardioverter-defibrillator lead adoption in the United States of America. Circ Arrhythm Electrophysiol. 2019;12:e7134.","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-021-01555-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-021-01555-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-021-01555-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T12:23:27Z","timestamp":1619094207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-021-01555-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1555"],"URL":"https:\/\/doi.org\/10.1007\/s12471-021-01555-w","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"17 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.F.\u00a0Groenveld, J.E.\u00a0Coster, D.J.\u00a0van Veldhuisen, M.\u00a0Rienstra, Y.\u00a0Blaauw and A.H.\u00a0Maass declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}